1 published article · Updated continuously
10 trials tracked for Hysterectomy: 6 in phase 3 or 4 and 3 with published results. The most-cited published study has 372 citations.
Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Bupivacaine and liposomal bupivacaine have been evaluated for postoperative pain management in hysterectomy patients. Bupivacaine was associated with specific metrics regarding opioid consumption (208, 203, or 202 mg morphine equivalents) and time to first opioid dose (51, 63, or 51 hours) 1. Liposomal bupivacaine demonstrated low Visual Analogue Scale (VAS) pain scores at rest over a 48-hour period, ranging from 2.1 to 3 4.
Morphine was shown to significantly impact the sum of pain intensity differences relative to baseline (p<0.0001) 6. Additionally, IV Acetaminophen (1 Gram) showed comparable results to placebo in the sum of pain intensity at rest from baseline to 24 hours (1793.3 vs 1845.3) and 48 hours (3612.4 vs 3718.2) 5.
Belladonna Opium was studied for post-operative pain, where VAS scores were recorded at 4.1 and 4.8 (p=0.17), and narcotic use was recorded at 19.3 and 21.3 (p=0.29) 3. Bupivacaine Hydrochloride 0.25% injection solution resulted in postoperative pain scores ranging between 5 and 6.3 2.
AI synthesis of 10 cited trials, updated Jun 26, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
